HEADER TRANSFERASE/TRANSFERASE INHIBITOR 27-JAN-12 4DHF TITLE STRUCTURE OF AURORA A MUTANT BOUND TO BIOGENIDEC CPD 15 COMPND MOL_ID: 1; COMPND 2 MOLECULE: AURORA KINASE A; COMPND 3 CHAIN: A, B; COMPND 4 FRAGMENT: UNP RESIDUES 126-391; COMPND 5 SYNONYM: AURORA 2, AURORA/IPL1-RELATED KINASE 1, ARK-1, AURORA- COMPND 6 RELATED KINASE 1, HARK1, BREAST TUMOR-AMPLIFIED KINASE, COMPND 7 SERINE/THREONINE-PROTEIN KINASE 15, SERINE/THREONINE-PROTEIN KINASE COMPND 8 6, SERINE/THREONINE-PROTEIN KINASE AURORA-A; COMPND 9 EC: 2.7.11.1; COMPND 10 ENGINEERED: YES; COMPND 11 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: AIK, AIRK1, ARK1, AURA, AURKA, AURORAA, AYK1, BTAK, IAK1, SOURCE 6 STK15, STK6; SOURCE 7 EXPRESSION_SYSTEM: SPODOPTERA FRUGIPERDA; SOURCE 8 EXPRESSION_SYSTEM_TAXID: 7108 KEYWDS SER/THR KINASE MITOTIC KINASE PYRAZOLOPYRIMIDINE, PHOSPHORYLATION, KEYWDS 2 TPX2, TRANSFERASE-TRANSFERASE INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR L.SILVIAN,D.J.MARCOTTE REVDAT 2 28-FEB-24 4DHF 1 REMARK SEQADV LINK REVDAT 1 18-JUL-12 4DHF 0 JRNL AUTH J.Y.LE BRAZIDEC,A.PASIS,B.TAM,C.BOYKIN,D.WANG,D.J.MARCOTTE, JRNL AUTH 2 G.CLAASSEN,J.H.CHONG,J.CHAO,J.FAN,K.NGUYEN,L.SILVIAN,L.LING, JRNL AUTH 3 L.ZHANG,M.CHOI,M.TENG,N.PATHAN,S.ZHAO,T.LI,A.TAVERAS JRNL TITL STRUCTURE-BASED DESIGN OF JRNL TITL 2 2,6,7-TRISUBSTITUTED-7H-PYRROLO[2,3-D]PYRIMIDINES AS AURORA JRNL TITL 3 KINASES INHIBITORS. JRNL REF BIOORG.MED.CHEM.LETT. V. 22 4033 2012 JRNL REFN ISSN 0960-894X JRNL PMID 22607669 JRNL DOI 10.1016/J.BMCL.2012.04.085 REMARK 2 REMARK 2 RESOLUTION. 2.80 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.5.0109 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.80 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 27.68 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 99.6 REMARK 3 NUMBER OF REFLECTIONS : 14580 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.210 REMARK 3 R VALUE (WORKING SET) : 0.206 REMARK 3 FREE R VALUE : 0.299 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 764 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.80 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.87 REMARK 3 REFLECTION IN BIN (WORKING SET) : 1044 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 99.54 REMARK 3 BIN R VALUE (WORKING SET) : 0.3480 REMARK 3 BIN FREE R VALUE SET COUNT : 47 REMARK 3 BIN FREE R VALUE : 0.4120 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 4222 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 78 REMARK 3 SOLVENT ATOMS : 0 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 59.40 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 0.09000 REMARK 3 B22 (A**2) : 0.09000 REMARK 3 B33 (A**2) : -0.13000 REMARK 3 B12 (A**2) : 0.04000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): NULL REMARK 3 ESU BASED ON FREE R VALUE (A): 0.463 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.344 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 17.433 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.943 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.881 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 4410 ; 0.011 ; 0.020 REMARK 3 BOND LENGTHS OTHERS (A): NULL ; NULL ; NULL REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 5970 ; 1.827 ; 1.986 REMARK 3 BOND ANGLES OTHERS (DEGREES): NULL ; NULL ; NULL REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 512 ; 7.882 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 210 ;38.152 ;22.762 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 764 ;22.196 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 38 ;21.878 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 630 ; 0.118 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 3358 ; 0.007 ; 0.021 REMARK 3 GENERAL PLANES OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 2649 ; 0.695 ; 1.500 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 4278 ; 1.280 ; 2.000 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 1915 ; 1.587 ; 3.000 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): 1901 ; 2.691 ; 4.500 REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN USED IF PRESENT IN REMARK 3 THE INPUT REMARK 4 REMARK 4 4DHF COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 30-JAN-12. REMARK 100 THE DEPOSITION ID IS D_1000070332. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : NULL REMARK 200 TEMPERATURE (KELVIN) : 90 REMARK 200 PH : 9 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 31-ID REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.00000 REMARK 200 MONOCHROMATOR : KOHZU HLD-4 DOUBLE CRYSTAL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : RAYONIX MX225HE REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : HKL-2000 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 15344 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.800 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 2.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.9 REMARK 200 DATA REDUNDANCY : 8.800 REMARK 200 R MERGE (I) : 0.06100 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 25.7000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.80 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.90 REMARK 200 COMPLETENESS FOR SHELL (%) : 100.0 REMARK 200 DATA REDUNDANCY IN SHELL : 8.60 REMARK 200 R MERGE FOR SHELL (I) : 0.52000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 20.00 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: MOLREP REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 51.67 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.55 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 1MM ADP, 2MM MGCL2 ADDITION AND SET UP REMARK 280 WITH 10% PEG550MME, 5% ETHYLENE GLYCOL, 0.1M TRIS, PH 9, VAPOR REMARK 280 DIFFUSION, SITTING DROP, TEMPERATURE 291K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 61 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -Y,X-Y,Z+1/3 REMARK 290 3555 -X+Y,-X,Z+2/3 REMARK 290 4555 -X,-Y,Z+1/2 REMARK 290 5555 Y,-X+Y,Z+5/6 REMARK 290 6555 X-Y,X,Z+1/6 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 2 0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 55.35500 REMARK 290 SMTRY1 3 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 3 -0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 110.71000 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 83.03250 REMARK 290 SMTRY1 5 0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 5 -0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 5 0.000000 0.000000 1.000000 138.38750 REMARK 290 SMTRY1 6 0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 6 0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 6 0.000000 0.000000 1.000000 27.67750 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 121 REMARK 465 PRO A 122 REMARK 465 LEU A 123 REMARK 465 GLY A 124 REMARK 465 SER A 125 REMARK 465 ARG A 126 REMARK 465 GLN A 127 REMARK 465 ARG A 286 REMARK 465 ASP A 287 REMARK 465 ASP A 288 REMARK 465 LEU A 289 REMARK 465 PRO A 390 REMARK 465 SER A 391 REMARK 465 GLY B 121 REMARK 465 PRO B 122 REMARK 465 LEU B 123 REMARK 465 GLY B 124 REMARK 465 SER B 125 REMARK 465 ARG B 126 REMARK 465 GLN B 127 REMARK 465 ARG B 286 REMARK 465 ASP B 287 REMARK 465 ASP B 288 REMARK 465 LEU B 289 REMARK 465 PRO B 390 REMARK 465 SER B 391 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 LYS A 171 CG CD CE NZ REMARK 470 LYS B 171 CG CD CE NZ REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 OE2 GLU A 336 OE1 GLU B 336 1.85 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 SER B 278 N - CA - C ANGL. DEV. = 16.8 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 LEU A 130 -71.49 -39.36 REMARK 500 ASP A 132 -28.12 134.53 REMARK 500 LYS A 143 -75.34 -51.87 REMARK 500 ARG A 179 31.59 -81.84 REMARK 500 ARG A 180 -30.90 -134.59 REMARK 500 ASP A 202 -155.28 -122.56 REMARK 500 SER A 226 -49.93 61.90 REMARK 500 ARG A 251 10.27 57.91 REMARK 500 ARG A 255 -2.67 72.66 REMARK 500 ASP A 256 40.58 -147.81 REMARK 500 ALA A 273 -165.40 -124.92 REMARK 500 ASP A 274 -102.39 70.70 REMARK 500 PHE A 275 140.83 69.61 REMARK 500 SER A 278 -137.21 -162.60 REMARK 500 VAL A 279 -158.30 -98.82 REMARK 500 HIS A 280 128.78 72.23 REMARK 500 ALA A 281 -169.51 48.66 REMARK 500 PRO A 282 175.98 -59.52 REMARK 500 SER A 284 -122.00 162.76 REMARK 500 THR A 292 17.91 19.82 REMARK 500 LEU A 293 -49.87 61.50 REMARK 500 ASP A 294 -43.10 -28.21 REMARK 500 ARG A 304 -167.08 -71.95 REMARK 500 LEU A 364 40.20 -94.07 REMARK 500 HIS A 380 116.01 -11.31 REMARK 500 ALA A 385 1.92 -63.08 REMARK 500 ASN A 386 -20.32 -155.10 REMARK 500 ASP B 132 -30.04 139.06 REMARK 500 LYS B 143 -75.40 -55.35 REMARK 500 LYS B 171 -4.35 -53.69 REMARK 500 VAL B 182 -70.44 -59.41 REMARK 500 ASP B 202 -160.16 -118.88 REMARK 500 SER B 226 -32.25 56.02 REMARK 500 ARG B 251 12.57 56.89 REMARK 500 ARG B 255 -6.17 67.72 REMARK 500 ASP B 256 31.47 -141.02 REMARK 500 ALA B 273 -166.63 -129.30 REMARK 500 ASP B 274 -102.87 71.78 REMARK 500 PHE B 275 163.45 78.31 REMARK 500 SER B 278 159.47 -19.65 REMARK 500 ALA B 281 -162.96 55.41 REMARK 500 SER B 284 69.35 100.32 REMARK 500 THR B 292 -74.57 61.81 REMARK 500 LEU B 293 -28.14 96.06 REMARK 500 ASP B 307 -159.68 -103.60 REMARK 500 THR B 337 -39.86 -35.77 REMARK 500 LEU B 364 49.39 -103.89 REMARK 500 HIS B 380 117.10 -23.30 REMARK 500 SER B 387 -167.41 -78.48 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: NON-CIS, NON-TRANS REMARK 500 REMARK 500 THE FOLLOWING PEPTIDE BONDS DEVIATE SIGNIFICANTLY FROM BOTH REMARK 500 CIS AND TRANS CONFORMATION. CIS BONDS, IF ANY, ARE LISTED REMARK 500 ON CISPEP RECORDS. TRANS IS DEFINED AS 180 +/- 30 AND REMARK 500 CIS IS DEFINED AS 0 +/- 30 DEGREES. REMARK 500 MODEL OMEGA REMARK 500 SER A 278 VAL A 279 -126.52 REMARK 500 REMARK 500 REMARK: NULL REMARK 620 REMARK 620 METAL COORDINATION REMARK 620 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 620 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 MG A 403 MG REMARK 620 N RES CSSEQI ATOM REMARK 620 1 ASN A 261 OD1 REMARK 620 2 PO4 A 402 O1 78.6 REMARK 620 N 1 REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 MG B 403 MG REMARK 620 N RES CSSEQI ATOM REMARK 620 1 ASN B 261 OD1 REMARK 620 2 PO4 B 402 O3 108.7 REMARK 620 N 1 REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 0K6 A 401 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE PO4 A 402 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE MG A 403 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 0K6 B 401 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE PO4 B 402 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC6 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE MG B 403 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 3R21 RELATED DB: PDB REMARK 900 AURORAA REMARK 900 RELATED ID: 3R22 RELATED DB: PDB REMARK 900 AURORAA DBREF 4DHF A 126 391 UNP O14965 AURKA_HUMAN 126 391 DBREF 4DHF B 126 391 UNP O14965 AURKA_HUMAN 126 391 SEQADV 4DHF GLY A 121 UNP O14965 EXPRESSION TAG SEQADV 4DHF PRO A 122 UNP O14965 EXPRESSION TAG SEQADV 4DHF LEU A 123 UNP O14965 EXPRESSION TAG SEQADV 4DHF GLY A 124 UNP O14965 EXPRESSION TAG SEQADV 4DHF SER A 125 UNP O14965 EXPRESSION TAG SEQADV 4DHF ASP A 287 UNP O14965 THR 287 ENGINEERED MUTATION SEQADV 4DHF ASP A 288 UNP O14965 THR 288 ENGINEERED MUTATION SEQADV 4DHF GLY B 121 UNP O14965 EXPRESSION TAG SEQADV 4DHF PRO B 122 UNP O14965 EXPRESSION TAG SEQADV 4DHF LEU B 123 UNP O14965 EXPRESSION TAG SEQADV 4DHF GLY B 124 UNP O14965 EXPRESSION TAG SEQADV 4DHF SER B 125 UNP O14965 EXPRESSION TAG SEQADV 4DHF ASP B 287 UNP O14965 THR 287 ENGINEERED MUTATION SEQADV 4DHF ASP B 288 UNP O14965 THR 288 ENGINEERED MUTATION SEQRES 1 A 271 GLY PRO LEU GLY SER ARG GLN TRP ALA LEU GLU ASP PHE SEQRES 2 A 271 GLU ILE GLY ARG PRO LEU GLY LYS GLY LYS PHE GLY ASN SEQRES 3 A 271 VAL TYR LEU ALA ARG GLU LYS GLN SER LYS PHE ILE LEU SEQRES 4 A 271 ALA LEU LYS VAL LEU PHE LYS ALA GLN LEU GLU LYS ALA SEQRES 5 A 271 GLY VAL GLU HIS GLN LEU ARG ARG GLU VAL GLU ILE GLN SEQRES 6 A 271 SER HIS LEU ARG HIS PRO ASN ILE LEU ARG LEU TYR GLY SEQRES 7 A 271 TYR PHE HIS ASP ALA THR ARG VAL TYR LEU ILE LEU GLU SEQRES 8 A 271 TYR ALA PRO LEU GLY THR VAL TYR ARG GLU LEU GLN LYS SEQRES 9 A 271 LEU SER LYS PHE ASP GLU GLN ARG THR ALA THR TYR ILE SEQRES 10 A 271 THR GLU LEU ALA ASN ALA LEU SER TYR CYS HIS SER LYS SEQRES 11 A 271 ARG VAL ILE HIS ARG ASP ILE LYS PRO GLU ASN LEU LEU SEQRES 12 A 271 LEU GLY SER ALA GLY GLU LEU LYS ILE ALA ASP PHE GLY SEQRES 13 A 271 TRP SER VAL HIS ALA PRO SER SER ARG ARG ASP ASP LEU SEQRES 14 A 271 CYS GLY THR LEU ASP TYR LEU PRO PRO GLU MET ILE GLU SEQRES 15 A 271 GLY ARG MET HIS ASP GLU LYS VAL ASP LEU TRP SER LEU SEQRES 16 A 271 GLY VAL LEU CYS TYR GLU PHE LEU VAL GLY LYS PRO PRO SEQRES 17 A 271 PHE GLU ALA ASN THR TYR GLN GLU THR TYR LYS ARG ILE SEQRES 18 A 271 SER ARG VAL GLU PHE THR PHE PRO ASP PHE VAL THR GLU SEQRES 19 A 271 GLY ALA ARG ASP LEU ILE SER ARG LEU LEU LYS HIS ASN SEQRES 20 A 271 PRO SER GLN ARG PRO MET LEU ARG GLU VAL LEU GLU HIS SEQRES 21 A 271 PRO TRP ILE THR ALA ASN SER SER LYS PRO SER SEQRES 1 B 271 GLY PRO LEU GLY SER ARG GLN TRP ALA LEU GLU ASP PHE SEQRES 2 B 271 GLU ILE GLY ARG PRO LEU GLY LYS GLY LYS PHE GLY ASN SEQRES 3 B 271 VAL TYR LEU ALA ARG GLU LYS GLN SER LYS PHE ILE LEU SEQRES 4 B 271 ALA LEU LYS VAL LEU PHE LYS ALA GLN LEU GLU LYS ALA SEQRES 5 B 271 GLY VAL GLU HIS GLN LEU ARG ARG GLU VAL GLU ILE GLN SEQRES 6 B 271 SER HIS LEU ARG HIS PRO ASN ILE LEU ARG LEU TYR GLY SEQRES 7 B 271 TYR PHE HIS ASP ALA THR ARG VAL TYR LEU ILE LEU GLU SEQRES 8 B 271 TYR ALA PRO LEU GLY THR VAL TYR ARG GLU LEU GLN LYS SEQRES 9 B 271 LEU SER LYS PHE ASP GLU GLN ARG THR ALA THR TYR ILE SEQRES 10 B 271 THR GLU LEU ALA ASN ALA LEU SER TYR CYS HIS SER LYS SEQRES 11 B 271 ARG VAL ILE HIS ARG ASP ILE LYS PRO GLU ASN LEU LEU SEQRES 12 B 271 LEU GLY SER ALA GLY GLU LEU LYS ILE ALA ASP PHE GLY SEQRES 13 B 271 TRP SER VAL HIS ALA PRO SER SER ARG ARG ASP ASP LEU SEQRES 14 B 271 CYS GLY THR LEU ASP TYR LEU PRO PRO GLU MET ILE GLU SEQRES 15 B 271 GLY ARG MET HIS ASP GLU LYS VAL ASP LEU TRP SER LEU SEQRES 16 B 271 GLY VAL LEU CYS TYR GLU PHE LEU VAL GLY LYS PRO PRO SEQRES 17 B 271 PHE GLU ALA ASN THR TYR GLN GLU THR TYR LYS ARG ILE SEQRES 18 B 271 SER ARG VAL GLU PHE THR PHE PRO ASP PHE VAL THR GLU SEQRES 19 B 271 GLY ALA ARG ASP LEU ILE SER ARG LEU LEU LYS HIS ASN SEQRES 20 B 271 PRO SER GLN ARG PRO MET LEU ARG GLU VAL LEU GLU HIS SEQRES 21 B 271 PRO TRP ILE THR ALA ASN SER SER LYS PRO SER HET 0K6 A 401 33 HET PO4 A 402 5 HET MG A 403 1 HET 0K6 B 401 33 HET PO4 B 402 5 HET MG B 403 1 HETNAM 0K6 7-CYCLOPENTYL-2-({1-METHYL-5-[(4-METHYLPIPERAZIN-1-YL) HETNAM 2 0K6 CARBONYL]-1H-PYRROL-3-YL}AMINO)-7H-PYRROLO[2,3- HETNAM 3 0K6 D]PYRIMIDINE-6-CARBOXAMIDE HETNAM PO4 PHOSPHATE ION HETNAM MG MAGNESIUM ION FORMUL 3 0K6 2(C23 H30 N8 O2) FORMUL 4 PO4 2(O4 P 3-) FORMUL 5 MG 2(MG 2+) HELIX 1 1 LYS A 166 GLY A 173 1 8 HELIX 2 2 VAL A 174 LEU A 188 1 15 HELIX 3 3 THR A 217 SER A 226 1 10 HELIX 4 4 ASP A 229 LYS A 250 1 22 HELIX 5 5 LYS A 258 GLU A 260 5 3 HELIX 6 6 PRO A 297 GLY A 303 1 7 HELIX 7 7 GLU A 308 GLY A 325 1 18 HELIX 8 8 THR A 333 VAL A 344 1 12 HELIX 9 9 THR A 353 LEU A 364 1 12 HELIX 10 10 ASN A 367 ARG A 371 5 5 HELIX 11 11 MET A 373 HIS A 380 1 8 HELIX 12 12 HIS A 380 ALA A 385 1 6 HELIX 13 13 LYS B 166 LYS B 171 1 6 HELIX 14 14 VAL B 174 LEU B 188 1 15 HELIX 15 15 THR B 217 SER B 226 1 10 HELIX 16 16 ASP B 229 LYS B 250 1 22 HELIX 17 17 LYS B 258 GLU B 260 5 3 HELIX 18 18 PRO B 297 GLU B 302 1 6 HELIX 19 19 GLU B 308 GLY B 325 1 18 HELIX 20 20 THR B 333 VAL B 344 1 12 HELIX 21 21 THR B 353 LEU B 364 1 12 HELIX 22 22 ASN B 367 ARG B 371 5 5 HELIX 23 23 MET B 373 HIS B 380 1 8 HELIX 24 24 HIS B 380 SER B 387 1 8 SHEET 1 A 5 PHE A 133 GLY A 140 0 SHEET 2 A 5 VAL A 147 GLU A 152 -1 O LEU A 149 N GLY A 136 SHEET 3 A 5 PHE A 157 PHE A 165 -1 O LEU A 159 N ALA A 150 SHEET 4 A 5 ARG A 205 LEU A 210 -1 O VAL A 206 N LEU A 164 SHEET 5 A 5 LEU A 196 HIS A 201 -1 N PHE A 200 O TYR A 207 SHEET 1 B 2 LEU A 262 LEU A 264 0 SHEET 2 B 2 LEU A 270 ILE A 272 -1 O LYS A 271 N LEU A 263 SHEET 1 C 5 PHE B 133 GLY B 140 0 SHEET 2 C 5 VAL B 147 GLU B 152 -1 O VAL B 147 N LEU B 139 SHEET 3 C 5 PHE B 157 PHE B 165 -1 O LEU B 159 N ALA B 150 SHEET 4 C 5 ARG B 205 LEU B 210 -1 O VAL B 206 N LEU B 164 SHEET 5 C 5 LEU B 196 HIS B 201 -1 N TYR B 197 O ILE B 209 SHEET 1 D 2 VAL B 252 ILE B 253 0 SHEET 2 D 2 VAL B 279 HIS B 280 -1 O VAL B 279 N ILE B 253 SHEET 1 E 2 LEU B 262 LEU B 264 0 SHEET 2 E 2 LEU B 270 ILE B 272 -1 O LYS B 271 N LEU B 263 LINK OD1 ASN A 261 MG MG A 403 1555 1555 2.23 LINK O1 PO4 A 402 MG MG A 403 1555 1555 2.42 LINK OD1 ASN B 261 MG MG B 403 1555 1555 1.91 LINK O3 PO4 B 402 MG MG B 403 1555 1555 2.46 CISPEP 1 GLY A 276 TRP A 277 0 11.20 CISPEP 2 SER A 283 SER A 284 0 -2.30 CISPEP 3 GLY B 276 TRP B 277 0 -7.45 CISPEP 4 TRP B 277 SER B 278 0 10.35 CISPEP 5 SER B 283 SER B 284 0 15.66 CISPEP 6 CYS B 290 GLY B 291 0 8.06 SITE 1 AC1 14 ARG A 137 LEU A 139 GLY A 140 VAL A 147 SITE 2 AC1 14 LEU A 210 GLU A 211 ALA A 213 PRO A 214 SITE 3 AC1 14 LEU A 215 GLY A 216 THR A 217 LEU A 263 SITE 4 AC1 14 PO4 A 402 SER B 342 SITE 1 AC2 6 LYS A 143 LYS A 162 ASN A 261 ASP A 274 SITE 2 AC2 6 0K6 A 401 MG A 403 SITE 1 AC3 2 ASN A 261 PO4 A 402 SITE 1 AC4 16 SER A 342 ARG B 137 LEU B 139 GLY B 140 SITE 2 AC4 16 VAL B 147 ALA B 160 LYS B 162 LEU B 210 SITE 3 AC4 16 GLU B 211 ALA B 213 PRO B 214 LEU B 215 SITE 4 AC4 16 GLY B 216 THR B 217 LEU B 263 PO4 B 402 SITE 1 AC5 6 LYS B 143 LYS B 162 ASN B 261 ASP B 274 SITE 2 AC5 6 0K6 B 401 MG B 403 SITE 1 AC6 3 ASN B 261 ASP B 274 PO4 B 402 CRYST1 81.590 81.590 166.065 90.00 90.00 120.00 P 61 12 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.012256 0.007076 0.000000 0.00000 SCALE2 0.000000 0.014152 0.000000 0.00000 SCALE3 0.000000 0.000000 0.006022 0.00000